HYDROCORTISONE cream Stati Uniti - inglese - NLM (National Library of Medicine)

hydrocortisone cream

e. fougera & co. a division of fougera pharmaceuticals inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 10 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

HYDROCORTISONE lotion Stati Uniti - inglese - NLM (National Library of Medicine)

hydrocortisone lotion

e. fougera & co. a division of fougera pharmaceuticals inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 25 mg in 1 ml - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

HYDROCORTISONE cream Stati Uniti - inglese - NLM (National Library of Medicine)

hydrocortisone cream

quality care products llc - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 25 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

HYDROCORTISONE lotion Stati Uniti - inglese - NLM (National Library of Medicine)

hydrocortisone lotion

padagis israel pharmaceuticals ltd - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 25 mg in 1 ml - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

HYDROCORTISONE BUTYRATE- hydrocortisone butyrate lotion lotion Stati Uniti - inglese - NLM (National Library of Medicine)

hydrocortisone butyrate- hydrocortisone butyrate lotion lotion

sola pharmaceuticals - hydrocortisone butyrate (unii: 05rmf7ypwn) (hydrocortisone - unii:wi4x0x7bpj) - none. 8.1 pregnancy pregnancy category c there are no adequate and well-controlled studies in pregnant women. therefore, hydrocortisone butyrate lotion should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. note: the animal multiples of human exposure calculations in this label were based on body surface area comparisons for an adult (i.e., mg/m 2 /day dose comparisons) assuming 100% human percutaneous absorption of a maximum topical human dose (mthd) for hydrocortisone butyrate lotion (25 g lotion). systemic embryofetal development studies were conducted in rats and rabbits. subcutaneous doses of 0.6, 1.8 and 5.4 mg/kg/day hydrocortisone butyrate were administered to pregnant female rats during gestation d

HYDROCORTISONE BUTYRATE- hydrocortisone butyrate lotion lotion Stati Uniti - inglese - NLM (National Library of Medicine)

hydrocortisone butyrate- hydrocortisone butyrate lotion lotion

preferred pharmaceuticals, inc. - hydrocortisone butyrate (unii: 05rmf7ypwn) (hydrocortisone - unii:wi4x0x7bpj) - none. 8.1 pregnancy pregnancy category c there are no adequate and well-controlled studies in pregnant women. therefore, hydrocortisone butyrate lotion should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. note: the animal multiples of human exposure calculations in this label were based on body surface area comparisons for an adult (i.e., mg/m 2 /day dose comparisons) assuming 100% human percutaneous absorption of a maximum topical human dose (mthd) for hydrocortisone butyrate lotion (25 g lotion). systemic embryofetal development studies were conducted in rats and rabbits. subcutaneous doses of 0.6, 1.8 and 5.4 mg/kg/day hydrocortisone butyrate were administered to pregnant female rats during gestation d

HC45 Hydrocortisone Acetate Cream (Hydrocortisone Acetate 1% w/w) Irlanda - inglese - HPRA (Health Products Regulatory Authority)

hc45 hydrocortisone acetate cream (hydrocortisone acetate 1% w/w)

reckitt benckiser ireland ltd - hydrocortisone acetate - cream - 1 percent weight/weight - corticosteroids, weak (group i); hydrocortisone

HYDROCORTISONE ACETATE PRAMOXINE HCL cream Stati Uniti - inglese - NLM (National Library of Medicine)

hydrocortisone acetate pramoxine hcl cream

padagis israel pharmaceuticals ltd - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - hydrocortisone acetate 2.5 g in 100 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.